FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4322758093> ?p ?o ?g. }

• W4322758093 endingPage "580" @default.
• W4322758093 startingPage "572" @default.
• W4322758093 abstract "Abstract Objective The microbiome plays an important role in a wide variety of skin disorders. Hence, dysbiosis in the skin and/or gut microbiome is associated with an altered immune response, promoting the development of skin diseases, such as atopic dermatitis, psoriasis, acne vulgaris and dandruff. Studies have shown that paraprobiotics may be promising for the treatment of skin disorders through microbiota modulation and immunomodulation. So, the objective is to develop an anti‐dandruff formulation using a paraprobiotic (Neoimuno) as active ingredient. Methods Randomized, double‐blind, placebo‐controlled clinical trial was performed in patients who had any degree of dandruff. A total of 33 volunteers were recruited and randomly divided into two groups: placebo or treated. (1% Neoimuno). The ingredient used was Neoimuno ( Bifidobacterium lactis strain CCT 7858). Combability analysis and perception questionnaire were applied before and after treatment. Statistical analyses were performed. Results No adverse effects were reported by patients throughout the study. Through the combability analysis, a significant decrease in the number of particles was verified after 28 days of shampoo use. Regarding perception, there was a significant difference for the cleaning variables and improvement of the general appearance 28 days after the intervention. There were no significant differences for the itching and scaling parameters, as well as the perception parameters at 14 days. Discussion Topical application of the paraprobiotic shampoo containing 1% Neoimuno was able to significantly improve the feeling of cleanliness and general aspects of dandruff, in addition to reducing scalp flakiness. Thus, with the results obtained through the clinical trial, Neoimuno presents itself as a natural, safe and effective ingredient in the treatment of dandruff. The efficacy of Neoimuno in dandruff was visible within 4 weeks." @default.
• W4322758093 created "2023-03-03" @default.
• W4322758093 creator A5006038888 @default.
• W4322758093 creator A5026560335 @default.
• W4322758093 creator A5032158520 @default.
• W4322758093 creator A5035182402 @default.
• W4322758093 creator A5045192177 @default.
• W4322758093 creator A5056456249 @default.
• W4322758093 creator A5062966056 @default.
• W4322758093 creator A5080251507 @default.
• W4322758093 creator A5089983151 @default.
• W4322758093 date "2023-06-20" @default.
• W4322758093 modified "2023-10-14" @default.
• W4322758093 title "<scp>Clinical evaluation of paraprobiotic‐associated</scp><i>Bifidobacterium lactis</i><scp>CCT</scp> 7858 <scp>anti‐dandruff shampoo efficacy</scp>: A <scp>randomized placebo‐controlled clinical trial</scp>" @default.
• W4322758093 cites W1721791423 @default.
• W4322758093 cites W1857378464 @default.
• W4322758093 cites W1972025764 @default.
• W4322758093 cites W2005831653 @default.
• W4322758093 cites W2020948549 @default.
• W4322758093 cites W2027023890 @default.
• W4322758093 cites W2036767516 @default.
• W4322758093 cites W2044590762 @default.
• W4322758093 cites W2072062048 @default.
• W4322758093 cites W2077400262 @default.
• W4322758093 cites W2082474458 @default.
• W4322758093 cites W2083707704 @default.
• W4322758093 cites W2088204655 @default.
• W4322758093 cites W2090640877 @default.
• W4322758093 cites W2164450900 @default.
• W4322758093 cites W2167497377 @default.
• W4322758093 cites W2280534763 @default.
• W4322758093 cites W2511062914 @default.
• W4322758093 cites W2512904520 @default.
• W4322758093 cites W2529973462 @default.
• W4322758093 cites W2742758459 @default.
• W4322758093 cites W2757190828 @default.
• W4322758093 cites W2763599576 @default.
• W4322758093 cites W2965572640 @default.
• W4322758093 cites W2995522736 @default.
• W4322758093 cites W3049555755 @default.
• W4322758093 doi "https://doi.org/10.1111/ics.12850" @default.
• W4322758093 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36862071" @default.
• W4322758093 hasPublicationYear "2023" @default.
• W4322758093 type Work @default.
• W4322758093 citedByCount "1" @default.
• W4322758093 countsByYear W43227580932023 @default.
• W4322758093 crossrefType "journal-article" @default.
• W4322758093 hasAuthorship W4322758093A5006038888 @default.
• W4322758093 hasAuthorship W4322758093A5026560335 @default.
• W4322758093 hasAuthorship W4322758093A5032158520 @default.
• W4322758093 hasAuthorship W4322758093A5035182402 @default.
• W4322758093 hasAuthorship W4322758093A5045192177 @default.
• W4322758093 hasAuthorship W4322758093A5056456249 @default.
• W4322758093 hasAuthorship W4322758093A5062966056 @default.
• W4322758093 hasAuthorship W4322758093A5080251507 @default.
• W4322758093 hasAuthorship W4322758093A5089983151 @default.
• W4322758093 hasConcept C126322002 @default.
• W4322758093 hasConcept C142724271 @default.
• W4322758093 hasConcept C16005928 @default.
• W4322758093 hasConcept C168563851 @default.
• W4322758093 hasConcept C197934379 @default.
• W4322758093 hasConcept C204787440 @default.
• W4322758093 hasConcept C27081682 @default.
• W4322758093 hasConcept C2776651480 @default.
• W4322758093 hasConcept C2777359526 @default.
• W4322758093 hasConcept C2777472678 @default.
• W4322758093 hasConcept C2778329239 @default.
• W4322758093 hasConcept C2779121184 @default.
• W4322758093 hasConcept C2780255968 @default.
• W4322758093 hasConcept C2781171460 @default.
• W4322758093 hasConcept C523546767 @default.
• W4322758093 hasConcept C54355233 @default.
• W4322758093 hasConcept C71924100 @default.
• W4322758093 hasConcept C86803240 @default.
• W4322758093 hasConcept C98274493 @default.
• W4322758093 hasConceptScore W4322758093C126322002 @default.
• W4322758093 hasConceptScore W4322758093C142724271 @default.
• W4322758093 hasConceptScore W4322758093C16005928 @default.
• W4322758093 hasConceptScore W4322758093C168563851 @default.
• W4322758093 hasConceptScore W4322758093C197934379 @default.
• W4322758093 hasConceptScore W4322758093C204787440 @default.
• W4322758093 hasConceptScore W4322758093C27081682 @default.
• W4322758093 hasConceptScore W4322758093C2776651480 @default.
• W4322758093 hasConceptScore W4322758093C2777359526 @default.
• W4322758093 hasConceptScore W4322758093C2777472678 @default.
• W4322758093 hasConceptScore W4322758093C2778329239 @default.
• W4322758093 hasConceptScore W4322758093C2779121184 @default.
• W4322758093 hasConceptScore W4322758093C2780255968 @default.
• W4322758093 hasConceptScore W4322758093C2781171460 @default.
• W4322758093 hasConceptScore W4322758093C523546767 @default.
• W4322758093 hasConceptScore W4322758093C54355233 @default.
• W4322758093 hasConceptScore W4322758093C71924100 @default.
• W4322758093 hasConceptScore W4322758093C86803240 @default.
• W4322758093 hasConceptScore W4322758093C98274493 @default.
• W4322758093 hasFunder F4320327939 @default.
• W4322758093 hasIssue "5" @default.
• W4322758093 hasLocation W43227580931 @default.
• W4322758093 hasLocation W43227580932 @default.

• next